Jingde Chen
YOU?
Author Swipe
View article: MDP: Multidimensional Vision Model Pruning with Latency Constraint
MDP: Multidimensional Vision Model Pruning with Latency Constraint Open
Current structural pruning methods face two significant limitations: (i) they often limit pruning to finer-grained levels like channels, making aggressive parameter reduction challenging, and (ii) they focus heavily on parameter and FLOP r…
View article: 20.4% Power conversion efficiency from albedo-collecting organic solar cells under 0.2 albedo
20.4% Power conversion efficiency from albedo-collecting organic solar cells under 0.2 albedo Open
Highly efficient bifacial organic solar cells (OSCs) have not been reported due to limited thickness of the active layer in conventional configurations, not allowing for efficient harvesting of front sunlight and albedo light. Here, bifaci…
View article: Multi-Dimensional Pruning: Joint Channel, Layer and Block Pruning with Latency Constraint
Multi-Dimensional Pruning: Joint Channel, Layer and Block Pruning with Latency Constraint Open
As we push the boundaries of performance in various vision tasks, the models grow in size correspondingly. To keep up with this growth, we need very aggressive pruning techniques for efficient inference and deployment on edge devices. Exis…
View article: Major strategies for improving the performance of perovskite solar cells
Major strategies for improving the performance of perovskite solar cells Open
Metal halide perovskite solar cell (PSC) has successfully distinguished itself in optoelectronic field by virtue of the sharp rise in power conversion efficiency over the past decade. The remarkable efficiency breakthrough at such a fast s…
View article: China special issue on gastrointestinal tumors‐Cetuximab retreatment plus camrelizumab and liposomal irinotecan in patients with <scp>RAS</scp> wild‐type metastatic colorectal cancer: Cohort B of the phase <scp>II CRACK</scp> study
China special issue on gastrointestinal tumors‐Cetuximab retreatment plus camrelizumab and liposomal irinotecan in patients with <span>RAS</span> wild‐type metastatic colorectal cancer: Cohort B of the phase <span>II CRACK</span> study Open
Patients with metastatic colorectal cancer (mCRC) have poor long‐term survival. Rechallenge with anti‐epidermal growth factor receptor (anti‐EGFR) based therapy has shown certain activity as late‐line therapy. To further improve clinical o…
View article: Supplementary Figure S3 from MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis
Supplementary Figure S3 from MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis Open
Supplementary Figure S3. The expression of caspase-1 and its association with MST1 in PDAC tissues. TMA PDAC specimens were immunostained with a specific anti-caspase-1 antibody. A. Representative images of caspase-1 expression were shown …
View article: Data from MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis
Data from MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis Open
Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease, and its incidence is increasing annually. It is critical to reveal and delineate the molecular mechanism promoting PDAC development and progression. Mammalian STE20-like kinase 1…
View article: Supplementary table S1 from MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis
Supplementary table S1 from MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis Open
Supplementary Table S1.MST1 expression and clinicopathologic characteristics of TMA
View article: Supplementary table S2 from MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis
Supplementary table S2 from MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis Open
Supplementary Table S2. Caspase-1 expression and clinicopathologic characteristics of TMA
View article: Supplementary Figure S4 from MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis
Supplementary Figure S4 from MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis Open
Supplementary Figure S4. ROS induces activation of caspase-1 in PDAC. BxPC-3 and FG cells were incubated with 0 mM, 15ï�M and 30ï�M H2O2 for 24hours. The levels of cl.caspase-1, mature-IL-1ï�¢ï€ andï€ mature-IL-18 were tested by western …
View article: Supplementary Figure S1 from MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis
Supplementary Figure S1 from MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis Open
Supplementary Figure S1. mRNA and protein levels of MST1 in PDAC tissues. The mRNA and protein of four paired PDAC tissues (TT) and its adjacent normal tissue (TN) were extracted. A, the protein levels of MST1 were tested by western blot. …
View article: Supplementary Figure S4 from MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis
Supplementary Figure S4 from MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis Open
Supplementary Figure S4. ROS induces activation of caspase-1 in PDAC. BxPC-3 and FG cells were incubated with 0 mM, 15ï�M and 30ï�M H2O2 for 24hours. The levels of cl.caspase-1, mature-IL-1ï�¢ï€ andï€ mature-IL-18 were tested by western …
View article: Supplementary Figure S2 from MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis
Supplementary Figure S2 from MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis Open
Supplementary Figure S2. The correlated levels of MST1, Caspase-1 and ROS in PDAC cell lines. A, The expression of caspase-1 was tested by western blot (For better understand of the results, some of the data were duplicated with Fig. 1A). …
View article: Supplementary table S1 from MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis
Supplementary table S1 from MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis Open
Supplementary Table S1.MST1 expression and clinicopathologic characteristics of TMA
View article: Supplementary table S2 from MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis
Supplementary table S2 from MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis Open
Supplementary Table S2. Caspase-1 expression and clinicopathologic characteristics of TMA
View article: Supplementary Figure S2 from MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis
Supplementary Figure S2 from MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis Open
Supplementary Figure S2. The correlated levels of MST1, Caspase-1 and ROS in PDAC cell lines. A, The expression of caspase-1 was tested by western blot (For better understand of the results, some of the data were duplicated with Fig. 1A). …
View article: Supplementary Figure S1 from MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis
Supplementary Figure S1 from MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis Open
Supplementary Figure S1. mRNA and protein levels of MST1 in PDAC tissues. The mRNA and protein of four paired PDAC tissues (TT) and its adjacent normal tissue (TN) were extracted. A, the protein levels of MST1 were tested by western blot. …
View article: Supplementary Figure S3 from MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis
Supplementary Figure S3 from MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis Open
Supplementary Figure S3. The expression of caspase-1 and its association with MST1 in PDAC tissues. TMA PDAC specimens were immunostained with a specific anti-caspase-1 antibody. A. Representative images of caspase-1 expression were shown …
View article: Data from MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis
Data from MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis Open
Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease, and its incidence is increasing annually. It is critical to reveal and delineate the molecular mechanism promoting PDAC development and progression. Mammalian STE20-like kinase 1…
View article: Additional file 1 of High USP32 expression contributes to cancer progression and is correlated with immune infiltrates in hepatocellular carcinoma
Additional file 1 of High USP32 expression contributes to cancer progression and is correlated with immune infiltrates in hepatocellular carcinoma Open
Table S1. DEGs between high- and low-USP32 expression HCC groups.
View article: A Novel Glycyrrhetinic Acid-Modified Oxaliplatin Liposome for Liver-Targeting and in vitro/vivo Evaluation [Retraction]
A Novel Glycyrrhetinic Acid-Modified Oxaliplatin Liposome for Liver-Targeting and in vitro/vivo Evaluation [Retraction] Open
[This retracts the article DOI: 10.2147/DDDT.S81722.].
View article: Preliminary experience of oral fruquintinib-capecitabine as a new maintenance treatment strategy for advanced colorectal cancer in the era of coronavirus disease 2019 (COVID-19): case report and literature review
Preliminary experience of oral fruquintinib-capecitabine as a new maintenance treatment strategy for advanced colorectal cancer in the era of coronavirus disease 2019 (COVID-19): case report and literature review Open
This case report based on preliminary evidence advocates oral fruquintinib-capecitabine maintenance treatment as an alternative to bevacizumab-capecitabine standard therapy for CRC patients, especially in the era of COVID-19 epidemic. This…
View article: miR-15a and miR-20b sensitize hepatocellular carcinoma cells to sorafenib through repressing CDC37L1 and consequent PPIA downregulation
miR-15a and miR-20b sensitize hepatocellular carcinoma cells to sorafenib through repressing CDC37L1 and consequent PPIA downregulation Open
Sorafenib is a classical targeted drug for the treatment of advanced hepatocellular carcinoma (HCC), but intrinsic resistance severely limited its therapeutic effects. In the present study, we aimed to identify crucial genes in HCC cells t…
View article: <scp>Hot‐electron emission‐driven</scp> energy recycling in transparent plasmonic electrode for organic solar cells
<span>Hot‐electron emission‐driven</span> energy recycling in transparent plasmonic electrode for organic solar cells Open
Plasmonic metal electrodes with subwavelength nanostructures are promising for enhancing light harvesting in photovoltaics. However, the nonradiative damping of surface plasmon polaritons (SPPs) during coupling with sunlight results in the…
View article: Recent advances in organic light-emitting diodes: toward smart lighting and displays
Recent advances in organic light-emitting diodes: toward smart lighting and displays Open
Recent advances in organic light-emitting diodes toward smart lighting and displays are reviewed in terms of materials, devices, fabrication and applications.
View article: Interfacial Energy Level Tuning for Efficient and Thermostable CsPbI<sub>2</sub>Br Perovskite Solar Cells
Interfacial Energy Level Tuning for Efficient and Thermostable CsPbI<sub>2</sub>Br Perovskite Solar Cells Open
Inorganic mixed‐halide CsPbX 3 ‐based perovskite solar cells (PeSCs) are emerging as one of the most promising types of PeSCs on account of their thermostability compared to organic–inorganic hybrid counterparts. However, dissatisfactory d…